Literature DB >> 8092177

The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients.

S K Inouye1.   

Abstract

Delirium, with occurrence rates from 14% to 56%, associated mortality rates from 10% to 65%, and excess annual health care expenditures from $1 to $2 billion, poses a common and serious problem for hospitalized elderly patients. Delirium is often unrecognized or misdiagnosed by physicians caring for elderly patients. Cognitive testing is rarely done as part of the admission evaluation of elderly hospitalized patients. Specific diagnosis has been difficult, since diagnostic criteria and instruments are still being developed. The etiology of delirium is complex and multifactorial, and both predisposing (host vulnerability) and precipitating factors must be considered. The recommended approach to the evaluation of delirium is empiric, in the absence of objective efficacy data. The cornerstone of evaluation includes a careful history, physical examination, and review of the medication list--since medications are the most common reversible cause of delirium. Research is needed to establish a cost-effective approach and to clarify the role of further testing, such as cerebrospinal fluid examination, brain imaging, and electroencephalography. This article is intended to heighten the awareness of clinicians as well as to stimulate research to address this important, neglected problem for elderly hospitalized patients.

Entities:  

Mesh:

Year:  1994        PMID: 8092177     DOI: 10.1016/0002-9343(94)90011-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  85 in total

Review 1.  Delirium: optimising management.

Authors:  D J Meagher
Journal:  BMJ       Date:  2001-01-20

2.  Prevalence and detection of delirium in elderly emergency department patients.

Authors:  M Elie; F Rousseau; M Cole; F Primeau; J McCusker; F Bellavance
Journal:  CMAJ       Date:  2000-10-17       Impact factor: 8.262

Review 3.  Assessing confused patients.

Authors:  M H Johnson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

Review 4.  An approach to drug induced delirium in the elderly.

Authors:  K Alagiakrishnan; C A Wiens
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

5.  The neuropsychological course of acute delirium in adult hematopoietic stem cell transplantation patients.

Authors:  Leigh J Beglinger; James A Mills; Stacie M Vik; Kevin Duff; Natalie L Denburg; Michelle T Weckmann; Jane S Paulsen; Roger Gingrich
Journal:  Arch Clin Neuropsychol       Date:  2010-12-23       Impact factor: 2.813

6.  Screening methods for delirium: don't get confused!

Authors:  Kees H Polderman
Journal:  Intensive Care Med       Date:  2006-11-11       Impact factor: 17.440

7.  Elderly patient with delirium after myocardial infarction.

Authors:  Meltem Halil; Eylem Sahin Cankurtaran; Nihal Ozkayar; Mustafa Cankurtaran; Zekeriya Ulger; Burcu Balam Yavuz; Ali Shorbagi; Servet Ariogul
Journal:  J Natl Med Assoc       Date:  2006-04       Impact factor: 1.798

8.  Care coordination for cognitively impaired older adults and their caregivers.

Authors:  Mary D Naylor; Karen B Hirschman; Kathryn H Bowles; M Brian Bixby; JoAnne Konick-McMahan; Caroline Stephens
Journal:  Home Health Care Serv Q       Date:  2007

9.  [Pharmacotherapy of elderly patients].

Authors:  H Burkhardt; M Wehling; R Gladisch
Journal:  Internist (Berl)       Date:  2007-11       Impact factor: 0.743

10.  Understanding international differences in terminology for delirium and other types of acute brain dysfunction in critically ill patients.

Authors:  A Morandi; P Pandharipande; M Trabucchi; R Rozzini; G Mistraletti; A C Trompeo; C Gregoretti; L Gattinoni; M V Ranieri; L Brochard; D Annane; C Putensen; U Guenther; P Fuentes; E Tobar; A R Anzueto; A Esteban; Y Skrobik; J I F Salluh; M Soares; C Granja; A Stubhaug; S E de Rooij; E Wesley Ely
Journal:  Intensive Care Med       Date:  2008-06-18       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.